These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22708457)

  • 21. Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule.
    Chriett S; Dąbek A; Wojtala M; Vidal H; Balcerczyk A; Pirola L
    Sci Rep; 2019 Jan; 9(1):742. PubMed ID: 30679586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of Rpd3 on fly metabolism, health, and longevity.
    Woods JK; Rogina B
    Exp Gerontol; 2016 Dec; 86():124-128. PubMed ID: 26927903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium butyrate enhances the cytotoxic effect of cisplatin by abrogating the cisplatin imposed cell cycle arrest.
    Koprinarova M; Markovska P; Iliev I; Anachkova B; Russev G
    BMC Mol Biol; 2010 Jun; 11():49. PubMed ID: 20576112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts.
    Chen JS; Faller DV
    J Cell Physiol; 2005 Jan; 202(1):87-99. PubMed ID: 15389542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging.
    Walsh ME; Bhattacharya A; Sataranatarajan K; Qaisar R; Sloane L; Rahman MM; Kinter M; Van Remmen H
    Aging Cell; 2015 Dec; 14(6):957-70. PubMed ID: 26290460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylases are required for amphibian tail and limb regeneration but not development.
    Taylor AJ; Beck CW
    Mech Dev; 2012; 129(9-12):208-18. PubMed ID: 22947425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The histone deacetylase inhibitor sodium butyrate decreases excessive ethanol intake in dependent animals.
    Simon-O'Brien E; Alaux-Cantin S; Warnault V; Buttolo R; Naassila M; Vilpoux C
    Addict Biol; 2015 Jul; 20(4):676-89. PubMed ID: 25041570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis.
    Inoue H; Shiraki K; Ohmori S; Sakai T; Deguchi M; Yamanaka T; Okano H; Nakano T
    Int J Mol Med; 2002 May; 9(5):521-5. PubMed ID: 11956660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactam-based HDAC inhibitors for anticancer chemotherapy: restoration of RUNX3 by posttranslational modification and epigenetic control.
    Cho M; Choi E; Kim JH; Kim H; Kim HM; Lee JI; Hwang KC; Kim HJ; Han G
    ChemMedChem; 2014 Mar; 9(3):649-56. PubMed ID: 24376239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting histone deacetylase in thyroid cancer.
    Russo D; Durante C; Bulotta S; Puppin C; Puxeddu E; Filetti S; Damante G
    Expert Opin Ther Targets; 2013 Feb; 17(2):179-93. PubMed ID: 23234477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Butyrate and Class I Histone Deacetylase Inhibitors Promote Differentiation of Neonatal Porcine Islet Cells into Beta Cells.
    Zhang Y; Lei Y; Honarpisheh M; Kemter E; Wolf E; Seissler J
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDAC modulation and cell death in the clinic.
    Dell'Aversana C; Lepore I; Altucci L
    Exp Cell Res; 2012 Jul; 318(11):1229-44. PubMed ID: 22336671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells.
    Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):905-11. PubMed ID: 20497425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.
    Gunin AG; Kapitova IN; Suslonova NV
    J Endocrinol; 2005 Jun; 185(3):539-49. PubMed ID: 15930180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the correct HDAC(s) to treat cognitive disorders.
    Fischer A; Sananbenesi F; Mungenast A; Tsai LH
    Trends Pharmacol Sci; 2010 Dec; 31(12):605-17. PubMed ID: 20980063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
    Frønsdal K; Saatcioglu F
    Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDAC inhibitors: A new promising drug class in anti-aging research.
    Pasyukova EG; Vaiserman AM
    Mech Ageing Dev; 2017 Sep; 166():6-15. PubMed ID: 28843433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.